Showing results (441-450 of 588) with videos related to

Sort By:
Pageof 59
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2014
Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptorsEddy J Chen, Adam G Sowalsky, Shuai Gao, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
NSD2 maintains lineage plasticity and castration-resistance in neuroendocrine prostate cancerJia J Li, Alessandro Vasciaveo, Dimitrios Karagiannis, et al.
The American Journal of Pathology|May 22, 2010
Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasisElisa Benedettini, Lynette M Sholl, Michael Peyton, et al.
Prostate Cancer and Prostatic Diseases|March 13, 2026
Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapySara Bleve, Francesco Ravera, Silvia Rodrigues, et al.
Cell|November 12, 2013
Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumorsBrooke M Emerling, Jonathan B Hurov, George Poulogiannis, et al.
Science (New York, N.Y.)|March 16, 2019
Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fateAbhishek A Chakraborty, Tuomas Laukka, Matti Myllykoski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2019
Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid FeaturesBradley A McGregor, Rana R McKay, David A Braun, et al.
British Journal of Cancer|December 21, 2019
A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinomaAmin H Nassar, Kent W Mouw, Opeyemi Jegede, et al.
Molecular Cancer Research : MCR|September 24, 2004
Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor typesIan Krop, Audrey Player, Ana Tablante, et al.
Pageof 59